Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial (Q33380938)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial |
scientific article |
Statements
1 reference
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial (English)
1 reference
Hartmut Goldschmidt
1 reference
Dietger Niederwieser
1 reference
Wolfram Pönisch
1 reference
Marta Rozanski
1 reference
Franz Albert Hoffmann
1 reference
Thomas Boldt
1 reference
Andreas Schwarzer
1 reference
Ute Ritter
1 reference
Robert Rohrberg
1 reference
Elke Schwalbe
1 reference
Jens Uhlig
1 reference
Thomas Zehrfeld
1 reference
Veronika Schirmer
1 reference
Antje Haas
1 reference
Ute Kreibich
1 reference
East German Study Group of Haematology and Oncology (OSHO)
1 reference
24 August 2008
1 reference
1 reference
Identifiers
1 reference